Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Urinary Concentrations of Polycyclic Aromatic Hydrocarbon Metabolites in Maté Drinkers in Rio Grande do Sul, Brazil.

Lopes AB, Metzdorf M, Metzdorf L, Sousa MPR, Kavalco C, Etemadi A, Pritchett NR, Murphy G, Calafat AM, Abnet CC, Dawsey SM, Fagundes RB.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):331-337. doi: 10.1158/1055-9965.EPI-17-0773. Epub 2017 Dec 20.

2.

LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.

DE Carli DM, Araujo AF, Fagundes RB.

Arq Gastroenterol. 2017 Dec;54(4):305-307. doi: 10.1590/s0004-2803.201700000-45. Epub 2017 Sep 21.

3.

IS THE IMMUNOCROMATOGRAPHIC FECAL ANTIGEN TEST EFFECTIVE FOR PRIMARY DIAGNOSIS OF HELICOBACTER PYLORI INFECTION IN DYSPEPTIC PATIENTS?

Dalla Nora M, Hörner R, De Carli DM, Rocha MP, Araujo AF, Fagundes RB.

Arq Gastroenterol. 2016 Oct-Dec;53(4):224-227. doi: 10.1590/S0004-28032016000400003.

4.

Immunohistochemical expression of HER2 in adenocarcinoma of the stomach.

De Carli DM, Rocha MP, Antunes LC, Fagundes RB.

Arq Gastroenterol. 2015 Apr-Jun;52(2):152-5. doi: 10.1590/S0004-28032015000200015.

5.

Peptic ulcer frequency differences related to h. Pylori or aines.

Carli DM, Pires RC, Rohde SL, Kavalco CM, Fagundes RB.

Arq Gastroenterol. 2015 Jan-Mar;52(1):46-9. doi: 10.1590/S0004-28032015000100010.

6.
7.

Diet and esophageal disease.

Dawsey SM, Fagundes RB, Jacobson BC, Kresty LA, Mallery SR, Paski S, van den Brandt PA.

Ann N Y Acad Sci. 2014 Sep;1325:127-37. doi: 10.1111/nyas.12528.

8.

Stepwise expression of CDKN2A and RB1 proteins in esophageal mucosa from patients at high risk for squamous cell carcinoma.

Müller LB, Meurer L, Lopes AB, Antunes LC, Vanazzi S, Fagundes RB.

Appl Immunohistochem Mol Morphol. 2014 Oct;22(9):669-73. doi: 10.1097/PAI.0000000000000011.

PMID:
25046224
9.

No evidence of HPV DNA in esophageal squamous cell carcinoma in a population of Southern Brazil.

Antunes LC, Prolla JC, de Barros Lopes A, da Rocha MP, Fagundes RB.

World J Gastroenterol. 2013 Oct 21;19(39):6598-603. doi: 10.3748/wjg.v19.i39.6598.

10.

Significant variation in the concentration of carcinogenic polycyclic aromatic hydrocarbons in yerba maté samples by brand, batch, and processing method.

Golozar A, Fagundes RB, Etemadi A, Schantz MM, Kamangar F, Abnet CC, Dawsey SM.

Environ Sci Technol. 2012 Dec 18;46(24):13488-93. doi: 10.1021/es303494s. Epub 2012 Dec 3.

11.

Gastric adenocarcinoma trends in the central region of Rio Grande do Sul (Southern Brazil): what has changed in 25 years?

Rampazzo A, Mott GL, Fontana K, Fagundes RB.

Arq Gastroenterol. 2012 Jul-Sep;49(3):178-83.

12.

Esophageal squamous cell carcinoma - precursor lesions and early diagnosis.

Lopes AB, Fagundes RB.

World J Gastrointest Endosc. 2012 Jan 16;4(1):9-16. doi: 10.4253/wjge.v4.i1.9.

13.
14.

Percutaneous endoscopic gastrostomy and peristomal infection: an avoidable complication with the use of a minimum skin incision.

Fagundes RB, Cantarelli JC Jr, Fontana K, Motta GL.

Surg Laparosc Endosc Percutan Tech. 2011 Aug;21(4):275-7. doi: 10.1097/SLE.0b013e318221c3f1.

PMID:
21857479
15.

Prevalence of anal intraepithelial neoplasia in women with genital neoplasia.

Koppe DC, Bandeira CB, Rosa MR, Cambruzzi E, Meurer L, Fagundes RB.

Dis Colon Rectum. 2011 Apr;54(4):442-5. doi: 10.1007/DCR.0b013e3182061b34.

PMID:
21383564
16.

Detecting p53 immunoexpression in esophageal mucosa with exfoliative cytology in individuals at risk for squamous cell carcinoma of the esophagus.

Lopes AB, Müller LB, Reichert R, Moraes CM, Capra AM, Prolla JC, Diehl AR, Meurer L, de Barros SG, Fagundes RB.

Acta Cytol. 2010 Jan-Feb;54(1):31-8.

PMID:
20306985
17.

Immunoreactivity of cytokeratins 7 and 20 in goblet cells and columnar blue cells in patients with endoscopic evidence of Barrett's esophagus.

Cantarelli JC Jr, Fagundes RB, Meurer L, Rocha MP, Nicola A, Kruel CD.

Arq Gastroenterol. 2009 Apr-Jun;46(2):127-31.

18.

P53 and Ki-67 overexpression in gastroesophageal reflux disease--Barrett's esophagus and adenocarcinoma sequence.

Binato M, Gurski RR, Fagundes RB, Meurer L, Edelweiss MI.

Dis Esophagus. 2009;22(7):588-95. doi: 10.1111/j.1442-2050.2009.00953.x. Epub 2009 Mar 6.

PMID:
19302208
19.

Nutrient patterns and risk of squamous cell carcinoma of the esophagus: a factor analysis in uruguay.

De Stefani E, Boffetta P, Fagundes RB, Deneo-Pellegrini H, Ronco AL, Acosta G, Mendilaharsu M.

Anticancer Res. 2008 Jul-Aug;28(4C):2499-506.

20.

High levels of carcinogenic polycyclic aromatic hydrocarbons in mate drinks.

Kamangar F, Schantz MM, Abnet CC, Fagundes RB, Dawsey SM.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1262-8. doi: 10.1158/1055-9965.EPI-08-0025.

21.

[Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].

Muller LB, Fagundes RB, Moraes CC, Rampazzo A.

Arq Gastroenterol. 2007 Apr-Jun;44(2):93-8. Portuguese.

22.

Esophageal tuberculosis.

Fagundes RB, Dalcin RP, Rocha MP, Moraes CC, Carlotto VS, Wink MO.

Endoscopy. 2007 Feb;39 Suppl 1:E149. Epub 2007 Jul 4. No abstract available.

PMID:
17611894
23.

pRB expression in esophageal mucosa of individuals at high risk for squamous cell carcinoma of the esophagus.

Contu SS, Contu PC, Damin DC, Fagundes RB, Bevilacqua F, Rosa AS, Prolla JC, Moreira LF.

World J Gastroenterol. 2007 Mar 21;13(11):1728-31.

24.

The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil.

Abnet CC, Fagundes RB, Strickland PT, Kamangar F, Roth MJ, Taylor PR, Dawsey SM.

Carcinogenesis. 2007 Jan;28(1):112-7. Epub 2006 Jul 24.

PMID:
16864595
25.
26.

p53 immunoexpression: an aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?

Fagundes RB, Melo CR, Pütten AC, Moreira LF, de Barros SG.

Cancer Detect Prev. 2005;29(3):227-32. Epub 2005 Apr 21.

PMID:
15936591
27.

p53 protein in esophageal mucosa of individuals at high risk of squamous cell carcinoma of the esophagus.

Fagundes RB, Mello CR, Tollens P, Pütten AC, Wagner MB, Moreira LF, Barros SG.

Dis Esophagus. 2001;14(3-4):185-90.

PMID:
11869317
28.

Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in southern Brazil.

Freitag CP, Barros SG, Kruel CD, Putten AC, Dietz J, Gruber AC, Diehl AS, Meurer L, Breyer HP, Wolff F, Vidal R, Arruda CA, Luz LP, Fagundes RB, Prolla JC.

Dis Esophagus. 1999;12(3):191-5.

PMID:
10631911
29.

Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.

Fagundes RB, de Barros SG, Pütten AC, Mello ES, Wagner M, Bassi LA, Bombassaro MA, Gobbi D, Souto EB.

Endoscopy. 1999 May;31(4):281-5.

PMID:
10376452

Supplemental Content

Loading ...
Support Center